Protein shedding in urothelial bladder cancer: prognostic implications of soluble urinary EGFR and EpCAM

por Bryan, R T, Regan, H L, Pirrie, S J, Devall, A J, Cheng, K K, Zeegers, M P, James, N D, Knowles, M A, Ward, D G
Publicado 2015

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential

por Bryan, R T, Shimwell, N J, Wei, W, Devall, A J, Pirrie, S J, James, N D, Zeegers, M P, Cheng, K K, Martin, A, Ward, D G
Publicado 2014

Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen—To Offer More? (aTTom) trial

por Bartlett, J M S, Sgroi, D C, Treuner, K, Zhang, Y, Ahmed, I, Piper, T, Salunga, R, Brachtel, E F, Pirrie, S J, Schnabel, C A, Rea, D W
Publicado 2019

Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression: A Randomized Clinical Trial

por Bryan, Richard T., Pirrie, Sarah J., Abbotts, Ben, Maycock, Shanna, During, Vinnie, Lewis, Carolyn, Grant, Margaret, Bird, Deborah, Devall, Adam J., Wallace, D. Michael A., James, Nicholas D., Billingham, Lucinda J., Zeegers, Maurice P., Cheng, K. K.
Publicado 2023

Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study

por Bartlett, John M.S., Sgroi, Dennis C., Treuner, Kai, Zhang, Yi, Piper, Tammy, Salunga, Ranelle C., Ahmed, Ikhlaaq, Doos, Lucy, Thornber, Sarah, Taylor, Karen J., Brachtel, Elena F., Pirrie, Sarah J., Schnabel, Catherine A., Rea, Daniel W.
Publicado 2022

The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study

por van Osch, Frits H. M., Jochems, Sylvia H. J., Reulen, Raoul C., Pirrie, Sarah J., Nekeman, Duncan, Wesselius, Anke, James, Nicholas D., Wallace, D. Michael A., Cheng, K. K., van Schooten, Frederik J., Bryan, Richard T., Zeegers, Maurice P.
Publicado 2018

Total Fluid Intake and the Risk of Recurrence in Patients With Non-Muscle Invasive Bladder Cancer: A Prospective Cohort Study

por Jochems, Sylvia H.J., van Osch, Frits H.M., Reulen, Raoul C., van Hensbergen, Mitch, Nekeman, Duncan, Pirrie, Sarah J., Wesselius, Anke, van Schooten, Frederik J., James, Nicholas D., Wallace, D. Michael A., Bryan, Richard T., Cheng, K.K., Zeegers, Maurice P.
Publicado 2018

Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23‐gene panel with utility for non‐invasive diagnosis and risk stratification

por Ward, Douglas G., Gordon, Naheema S., Boucher, Rebecca H., Pirrie, Sarah J., Baxter, Laura, Ott, Sascha, Silcock, Lee, Whalley, Celina M., Stockton, Joanne D., Beggs, Andrew D., Griffiths, Mike, Abbotts, Ben, Ijakipour, Hanieh, Latheef, Fathimath N., Robinson, Robert A., White, Andrew J., James, Nicholas D., Zeegers, Maurice P., Cheng, K. K., Bryan, Richard T.
Publicado 2019